Oramed Pharmaceuticals Inc (ORMP): Oramed to Present at Novel Therapies for...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	145
Posts	27561
Boards Moderated	3
Alias Born	02/07/2004

midastouch017

Re: None

Thursday, 05/18/2023 8:51:18 AM

Thursday, May 18, 2023 8:51:18 AM

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

https://finance.yahoo.com/news/oramed-present-novel-therapies-type-115500024.html

NEW YORK, May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed's oral delivery technology as well as insights from the Company's recent Phase 3 oral insulin clinical trials.

Presentation Details:

Novel Therapies for Type 2 Diabetes & Obesity Summit

Date: Wednesday, May 31, 2023

Time: 1:30 p.m. E.T.

Location: Hyatt Regency Boston, Boston, MA

For more information regarding the summit and the presentation, please visit the Summit's website: Home - Novel Therapies for Type 2 Diabetes & Obesity Summit 2023 (t2d-obesity-summit.com)